Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER

Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/157

Title:	Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER
Authors:	De Giorgi, Riccardo
Keywords:	Depressive Disorders Antidepressant Drugs
Issue Date:	17-Dec-2018
Citation:	Riccardo de Giorgi. Vortioxetine for depression: the evidence for its current use in the UK: COMMENTARY ON… COCHRANE CORNER. BJPsych Advances Vol 25. 1 2019 p3-6.
Abstract:	The pharmacological treatment of depression is often hampered by side-effects and unsatisfactory response to treatment. Vortioxetine is one of the newest antidepressants on the market, purportedly with a different mechanism of action compared with other antidepressants. This month's Cochrane Corner review examines the evidence available for the use of vortioxetine as a first-line treatment for depression in adults. This commentary puts the Cochrane review's findings into their clinical context and revises them in view of earlier and later studies
Description:	The article attached to this record is the Author(s) pre-/post- print version only. NOTE: this is not the version published in BJPsych Advances. Minor changes may have been made for publication. Eligible users can access the full text via NHS OpenAthens (login required)
URI:	https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/157
ISSN:	2056-4686
Appears in Collections:	Depressive Disorders BJPsych Advances publications

Files in This Item:

File	Description	Size	Format
BJPsych Adv Round the corner - Vortioxetine for depression in adults.pdf	PrePrint	225.17 kB	Adobe PDF	View/Open

DSpace JSPUI